Search Results 1531-1540 of 17021 for monoclonal antibody

1. TruGraf® Long-term Clinical Outcomes Study

   ... antibody-mediated rejection (ABMR). Patients with subclinical ABMR had the poorest graft survival at 8 years post-transplant (56%) compared with subclinical ...

2. Autoimmune epilepsy - Care at Mayo Clinic

   Mayo Clinic Laboratories was one of the first centers to offer an autoimmune encephalitis panel to check for antibodies and test for autoimmune epilepsy.

3. Mayo Clinic Minute: What is CAR-T cell therapy?

   Patients who are newly diagnosed with lymphoma are offered a combination of chemotherapy and antibody-based treatments. But for those who do not respond to ...

4. Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung - Mayo Clinic

   Participation eligibility · Children in care. · Prior exposure to VEGFR tyrosine kinase inhibitor (small molecule or antibody) or VEGFR antibody. · Prior ...

5. Clinical trials - Oncology (Medical)

   This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

6. A Study to Evaluate Intravenous TAEK-VAC-HerBy Vaccine Alone and in Combination Treatment in patients with advanced cancer - Mayo Clinic

   The primary purposes of this study are to is to assess safety and tolerability of IV administration of TVH vaccine alone and in combination with HER2 antibodies ...

7. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   ... antibody (HBc Ab) positive (+) subjects;. HCV: HCV ribonucleic acid (RNA) detectable in any subject with anti-HCV antibody (HCV Ab);. HIV: confirmed positive ...

8. Anthrax immune globulin (intravenous route) - Mayo Clinic

   IgA (immunoglobulin A) deficiency with antibodies against IgA—Should not be given to patients with these conditions. Blood clotting problems or; Diabetes or ...

9. A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell Conditions - Mayo Clinic

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

10. Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies - Mayo Clinic

    Subjects are eligible with or without a documented complement mutation or anti-CFH antibody. Subjects are categorized according to their response to plasma ...